| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Sep 15, 2025 | Mersana Therapeutics, Inc. | CEO | Sell | 23.8 | -2,012 | -17.37% | ✓ | $14.7K |
| May 19, 2025 | May 19, 2025 | Syndax Pharmaceuticals Inc | Director | Buy | 86.3 | +5,000 | 6.76% | ✗ | $45K |
| Jan 15, 2025 | Jan 17, 2025 | Mersana Therapeutics, Inc. | CEO | Sell | 42.5 | -4,514 | -3.54% | ✓ | $2.6K |
| Sep 11, 2024 | Sep 13, 2024 | Mersana Therapeutics, Inc. | CEO | Sell | 10.0 | -50,423 | -30.24% | ✓ | $88.7K |